Sub-category: Tissue Engineering & Cell Therapy
Medical field: Endocrinology
A development stage private Israeli company owned by USA public company ORGS:OTCBB). Orgenesis aimed to cure dibetes by receiving liver biopsy from the diabetic patient, in our facilities we propagate and reprogram those cells to become Autologous Insulin Producing cells (AIP) and then transplant the AIP cells back into the patient liver in a similar process as the Pancreatic Islet transplantation. The AIP cells becomes active within days folowing the transplantation, monitoring the blood glucose level and secrete insulin accordingly.
|Jacob BenArie, CEO|
To update your company data, click here.